Publications by authors named "C Souty"
Background: In France, mumps surveillance is conducted in primary care by the Sentinelles network, the National Reference Centre for Measles, Mumps and Rubella and Santé publique France.
Aim: The objective of this study was to estimate the incidence of suspected mumps in general practice, the proportion of laboratory confirmed cases and the factors associated with a virological confirmation.
Methods: General practitioners (GPs) participating in the Sentinelles network should report all patients with suspected mumps according to a clinical definition in case of parotitis and a serological definition in case of clinical expression without parotitis.
Article Synopsis
- Serological testing for Lyme borreliosis (LB) in patients with erythema migrans (EM) is not advised per European guidelines, prompting a study on French general practitioners' (GPs) adherence to these recommendations.
- The study included 1,831 EM cases and found that only 24.0% resulted in a serological test prescription, showing a significant decline from 46.8% in 2009 to 15.8% in 2020.
- Key factors leading to serological test prescriptions included the absence of a reported tick bite, presence of multiple EM lesions, larger EM size, and GPs who diagnosed fewer than one EM case per year, indicating a
Background: Influenza-like illness (ILI) incidence estimates in individuals treated with immunosuppressants and/or biologics and/or corticosteroid for an autoimmune or chronic inflammatory disease are scarce. We compared the ILI incidence among immunocompromised population and the general population.
Method: We conducted a prospective cohort study during the 2017-2018 seasonal influenza epidemic, on the GrippeNet.
Article Synopsis
- The study investigated the prevalence and bleeding risk associated with drug interactions between apixaban or rivaroxaban and certain CYP3A4 and P-glycoprotein inhibitors in patients with atrial fibrillation (AF).
- Using a cohort from the French healthcare database (2014-2019), 10,392 AF patients on these medications were analyzed, with a focus on hospitalization due to bleeding as the primary outcome.
- The findings revealed a 38.9% prevalence of drug-drug interactions, but no significant association with increased hospitalization for bleeding; factors like age and male gender were related to higher bleeding risk instead.